Biotech M&A, Earnings to Rise, Werber Says

Nov. 5 (Bloomberg) -- Yaron Werber, biotechnology analyst at Citigroup Inc., talks with Bloomberg Industries senior healthcare analyst Andrew Berens and Bloomberg's Sasha Damouni about the biotechnology industry and the outlook for earnings and mergers and acquisitions. (This is an excerpt. Source: Bloomberg)